Effects of family integrated care on weight gain in extremely preterm infants

Jiangfeng Ou1, Xiaoyun Zhong1, Xiaoting Zhang2

  • 1Department of Pediatrics, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.

Minerva Pediatrics
|June 21, 2021
PubMed

Insights

Family integrated care (FICare) significantly enhances weight gain in preterm infants. This approach partners families with neonatal intensive care units (NICUs) for improved infant health outcomes.

Area of Science:

  • Neonatal Intensive Care
  • Pediatric Health Outcomes
  • Family-Centered Care

Background:

  • Family integrated care (FICare) involves families as partners in neonatal intensive care units (NICUs).
  • FICare has the potential to improve health outcomes for preterm infants.
  • This study investigated the impact of FICare on extremely preterm infants.

Purpose of the Study:

  • To explore the effect of Family Integrated Care (FICare) on extremely preterm infants.
  • To evaluate the impact of integrating families into neonatal intensive care unit (NICU) care.
  • To assess changes in weight gain and other health indicators in preterm infants under FICare.

Main Methods:

  • A cohort of 182 preterm infants was studied from June 2017 to June 2018.
  • Sixty-six infants were enrolled in the FICare group, with 66 matched controls.
  • Statistical analysis, including linear regression, was performed using SPSS v. 20.0.

Main Results:

  • The FICare group showed higher weight gain rates, oxygen exposure, hospitalization costs, and retinopathy of prematurity (ROP) incidence.
  • Factors like elevated birth weight, maternal age, and hormone use influenced weight growth rates.
  • The weight growth rate was significantly increased in the FICare group compared to the control group (P<0.001).

Conclusions:

  • Family integrated care (FICare) significantly improves weight gain in preterm infants.
  • FICare is beneficial for infants born at or before 32 weeks gestation.
  • Integrating families into NICU care positively impacts infant growth during hospitalization.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
43
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
399
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
843
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
472
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
59
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
388